Learn how genetic testing can provide better answers for the best prostate cancer treatment for you in our FREE Patient Testing Guide.
We are here to help! If you can answer ‘yes’ to any of the following, we can provide educational information to your Urologist.
Are you:
Newly diagnosed with prostate cancer?
Currently on active surveillance?
If you are interested and would like us to reach out to your provider, please fill out their information below
You agree to be contacted with newsletters, marketing or promotional materials and other information that may be of interest to you. You may opt-out of receiving communications from us by following the unsubscribe link or the instructions provided in any email we send. For further information on our privacy practices and commitment to protecting your privacy, please visit our Privacy Policy.
Contact Information
Myriad Urology’s genetic tests provide personalized information about your prostate cancer, empowering you and your doctor to make informed treatment decisions with confidence.
A prostate cancer diagnosis can be scary. Your imagination might be working overtime, playing out best- and worst-case scenarios. It’s normal. There’s so much to consider about which prostate cancer treatment is right for you, and the unknown can be unsettling.
Genetic testing can bring clarity to the uncertainty by providing you and your doctor with specific details on your prostate cancer. This arms both of you with the information needed to select the best prostate cancer treatment option for you.
With genetic testing, you gain powerful knowledge to navigate your prostate cancer journey with greater confidence and clarity, helping you and your doctor answer important questions such as:
Genetic testing of your tumor using the Prolaris Prostate Cancer Prognostic Test goes beyond traditional diagnostic tools like PSA levels and Gleason score, identifying important details to better understand how quickly your cancer is growing and how aggressive it is. This information can tell you and your provider if you’re safe to avoid treatment in favor of active surveillance, or if it makes sense to pursue surgery, radiation, or other forms of treatment.
The comprehensive Prolaris report includes a molecular score, test recommendations, and detailed risk assessments for various treatment approaches, including the consideration of adding hormone therapy to radiation. For a deeper understanding of your Prolaris results and their implications, you can refer to the Understanding My Prolaris Report resource, which explains the report’s structure in detail.
Request our FREE patient guide to get started, or learn more about Prolaris
Men who are newly diagnosed and untreated or currently on active surveillance should pursue the Prolaris test to understand which treatment plan is right for you and your cancer. Men who have already been treated for prostate cancer, have high-risk, or metastatic prostate cancer, should consider the Myriad MyRisk germline test. Germline testing helps men understand if they qualify for new therapies and if their families have an elevated risk of developing cancer in the future.
There are a few different tests to help you make more informed treatment decisions. One type of testing is known as “genomic” testing. Prolaris is a genomic test that looks at a cancers behavior to determine how aggressive it is. Another type of test, known as germline testing, looks at DNA to help men know if their cancer is hereditary. Hereditary cancers are generally more aggressive than non-hereditary types and new life extending therapies are available for men with this type of cancer. MyRisk is Myriad’s gold standard germline test.
Genetic testing for prostate cancer is a straightforward process designed with your comfort in mind. Here's what you can expect:
This simple yet powerful test can provide you and your doctor with important insights to inform your prostate cancer journey, all from a single sample.
Your MyRisk test results can provide valuable insights into your inherited prostate cancer risk. Here's what different results could mean for you:
Positive Result
A positive MyRisk result means we've found a genetic change linked to higher hereditary prostate cancer risk. If this happens, your doctor might recommend more frequent check-ups or discuss ways to lower your risk. This information can also be helpful for your family members.
Negative Result
A negative MyRisk result means we didn't find any known inherited genetic changes that increase your prostate cancer risk. While this is good news, it's important to remember that other factors can still affect your risk. Your doctor will help you understand what this means for your ongoing care.
Uncertain Result
Sometimes, we find a genetic change in the MyRisk test but aren't sure yet how it affects cancer risk. If this happens, don't worry—it doesn't necessarily mean you have a high risk. Your doctor will explain what this means for you and keep you updated if we learn more in the future.
“It had affected my family as much as it had affected just me.”
Ed Hoppe
MyRisk is a germline test that offers a multi-gene panel to determine a patient’s risk of developing secondary cancers, as well as their children’s risk for the same germline mutations. MyRisk can also qualify patients for newer, personalized treatments such as PARP and immunotherapy.
Hereditary cancer test capable of identifying secondary cancer risk to inform treatment decisions and help notify family members who may have inherited the same genetic mutation.
A somatic test that assesses 500+ genes, as well as key biomarkers like MSI, TMB and PD-L1, to determine if a patient’s tumor may be appropriate for novel therapies or clinical trials.
Discover and target important variants only found within the tumors and qualify for new therapies and the most relevant clinical trials.
A cell-cycle proliferation-based biomarker that provides results as early as your patient’s first cancer consultation and determines how aggressive the cancer is behaving. Prolaris eliminates guesswork around cancer risk by combining clinical and pathological features with a personalized tumor aggressiveness score.
A genetic test for untreated men with prostate cancer that can determine how aggressive the cancer may be, how quickly it is growing and which treatment is right for you.
Prolaris® is a molecular diagnostic test that helps determine the aggressiveness of a prostate cancer tumor to guide the best treatment decisions for prostate cancer patients.
Myriad has invested over 30 years in developing tests and solutions that help provide the best answers and care possible.Our tests are:
Myriad is committed to providing patients with access to accurate and affordable genetic results through excellent insurance coverage and financial assistance programs.
Myriad tests offer industry-leading accuracy so you can feel confident in the results. From hereditary cancer to precision medicine, our tests are designed to give providers and patients the most accurate answers possible.
Myriad makes genetic testing simple with clear, actionable results. We create easy-to-understand reports to ensure that both patients and their providers can use the information to guide treatment options based on national medical guidelines.
Myriad believes that results and genetic information belong to the patient. We take multiple steps to ensure that the security and privacy of patient data is not compromised, and we believe that patients should be in control of their information.
Welcome back to my blog! In this final post of 2024, we’ll explore the importance of Family Health History Month and how men can take the lead in gathering a...
Prostate cancer affects many men, but not all cases require immediate treatment. For some, the cancer grows slowly and may never pose a serious health risk. Ac...